Literature DB >> 17593342

[Modification of the histopathologic degree of inflammation in asymptomatic prostatitis (NIH IV) by moxifloxacin].

T Bschleipfer1, F M E Wagenlehner, W Weidner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17593342     DOI: 10.1007/s00120-007-1383-9

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  23 in total

1.  Prospective identification of National Institutes of Health category IV prostatitis in men with elevated prostate specific antigen.

Authors:  J M Potts
Journal:  J Urol       Date:  2000-11       Impact factor: 7.450

2.  Elevated serum prostate-specific antigen due to acute bacterial prostatitis.

Authors:  D L Dalton
Journal:  Urology       Date:  1989-06       Impact factor: 2.649

Review 3.  Consensus development of a histopathological classification system for chronic prostatic inflammation.

Authors:  J C Nickel; L D True; J N Krieger; R E Berger; A H Boag; I D Young
Journal:  BJU Int       Date:  2001-06       Impact factor: 5.588

4.  Treatment of chronic prostatitis lowers serum prostate specific antigen.

Authors:  Caleb B Bozeman; Brett S Carver; James A Eastham; Dennis D Venable
Journal:  J Urol       Date:  2002-04       Impact factor: 7.450

5.  Prostate-specific antigen (PSA) value change after antibacterial therapy of prostate inflammation, as a diagnostic method for prostate cancer screening in cases of PSA value within 4-10 ng/ml and nonsuspicious results of digital rectal examination.

Authors:  G Karazanashvili; L Managadze
Journal:  Eur Urol       Date:  2001-05       Impact factor: 20.096

6.  Can complexed prostate specific antigen and prostatic volume enhance prostate cancer detection in men with total prostate specific antigen between 2.5 and 4.0 ng./ml.

Authors:  K Okihara; H A Fritsche; A Ayala; D A Johnston; W J Allard; R J Babaian
Journal:  J Urol       Date:  2001-06       Impact factor: 7.450

7.  Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer.

Authors:  M K Brawer; C D Cheli; I E Neaman; J Goldblatt; C Smith; M K Schwartz; D J Bruzek; D L Morris; L J Sokoll; D W Chan; K K Yeung; A W Partin; W J Allard
Journal:  J Urol       Date:  2000-05       Impact factor: 7.450

8.  [Prostatitis syndrome].

Authors:  Florian M E Wagenlehner; H Schneider; W Weidner
Journal:  Urologe A       Date:  2007-02       Impact factor: 0.639

9.  Prostate specific antigen and prostatitis. I. Effect of prostatitis on serum PSA in the human and nonhuman primate.

Authors:  D E Neal; S Clejan; D Sarma; T D Moon
Journal:  Prostate       Date:  1992       Impact factor: 4.104

10.  Diffusion of oral and intravenous 400 mg once-daily moxifloxacin into lung tissue at pharmacokinetic steady-state.

Authors:  D Breilh; J Jougon; S Djabarouti; J B Gordien; F Xuereb; J F Velly; P Arvis; V Landreau; M C Saux
Journal:  J Chemother       Date:  2003-12       Impact factor: 1.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.